Reports for government, local and international organisations

Feasibility study of a combined animal and human vaccine initiative in SA.
Generated for the SA Department of Science and Technology, 2010.

Systems analysis of the interface between South African primary health clinics and the National Health Laboratory Service.
Generated for the US Centers for Disease Control and Prevention and the SA Department of Health, 2010. Report available as PDF: Part A and Part B.

Analysis of POCT/VCT performed at South African primary health care clinics. Generated for US Centres for Disease Control and Prevention,and the SA
Department of Health, 2010. Report available as PDF.

African AIDS Vaccine Program Strategic Plan – 2007 to 2011. Generated for the World Health Organisation, 2007.

Guidance document for the development of National Laboratory Strategic Plans. Generated for the WHO and Centers for Disease Control and Prevention, 2010. Available as a PDF.

Guidance document for the development of National AIDS Vaccine Strategic Plans.
Generated for the WHO, 2006.

Review of Climate Change and Health research and activities in Southern Africa.
Generated as a subcontract from the UK Department for International Development, 2010. Available as PDF.

Strategic Review of the European Union funded HIV vaccine activities in Mbeya and Dar es Salaam, Tanzania. Generated for the European Union, 2006.

Feasibility study: A preclinical animal facility in South Africa.
Generated for the Cape Biotech Trust, 2006.

Funding strategy document: HIV Managed Care Solutions (Pty) Ltd, trading as CareWorks, 2006.

Strategy document: The Circulatory Diseases Research Foundation of South Africa, 2006.

Phase I and II Clinical Trial Protocols and Investigator Brochures for Biovac Institute product development of both a novel Haemophilus Influenza Type B vaccine and a novel Pentavalent vaccine containing HBV, DTP and Hib, 2009.

The Biovac Institute: Research and Development Strategy, 2006.

The Biovac Institute funding options within South Africa, 2007.

Strategic evaluation reports of donor-funded and other organisations

Strategic evaluation of the SA HIV Clinicians Society, generated on behalf of Atlantic Philanthropies, 2010.

Strategic evaluation of the Democratic Nursing Organisation of SA (DENOSA), and their Professional Development Institute, generated on behalf of Atlantic Philanthropies, 2010.

Strategic evaluation of the SA Nursing Educators Association (NEA), generated on behalf of Atlantic Philanthropies, 2010.

Full strategic evaluation and strategy development of the following organisations involved in HIV activities, on behalf of the US Centers for Disease Control and Prevention, 2007 - 2010:

• Newstart division of Society for Family Health;
• HIV Managed Care Solutions (Pty) Ltd, trading as CareWorks.
• African Medical Research Foundation
• Aurum Health Institute
• Department of Correctional Services
• Health Sciences Academy
• University of KwaZulu-Natal Traditional Healers Program
• Toga Laboratories
• University Research Company
• Columbia University’s International Centre for AIDS Care and Treatment
• Program in SA

Strategic evaluation of the following entities, on behalf of DEG-KFW Group (the German development bank), 2008.

• Interbrand
• Brandcorp
• Matus

Academic journal articles

Kaleebu P, Abimiku A, El-Halabi S, Koulla-Shiro S, Mboup S, Nkengasong J, Toure-Kane C, Tucker T, Wassenaar D, Williamson C, Wolday D. African AIDS Vaccine Programme Strategic Plan for a Co-ordinated and Collaborative Vaccine Development Effort on the Continent. PLoS Medicine Dec 2008; Vol. 5.

Tucker TJ, Makgoba MW. Public-Private Partnerships and Scientific Imperialism. Science 23 May 2008; 320 (5879): 1016–1017.

WHO/UNAIDS/AAVP International Expert Group. T.J. Tucker a primary contributor and author of this paper. Inclusion of adolescents in HIV vaccine trials. J Acquir Immune Defic Syndr 2007.

Jaspan HB, Cunningham CK, Tucker TJ, Wright PF, Self SG, Sheets RL, Allen MA, Rogers AS, Bekker L-G, Wilson CM, Duerr A, Wasserheit JN. HIV Vaccine Trials Network Adolescent Working Group Position Paper: Routine inclusion of adolescents in prophylactic HIV vaccine development. J AIDS Epidemiol; Nov 2007.